Detalles de la búsqueda
1.
Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer.
Cell
; 170(2): 352-366.e13, 2017 Jul 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-28709002
2.
Adjuvant platinum versus capecitabine for residual, invasive, triple-negative breast cancer: Patient-reported outcomes in ECOG-ACRIN EA1131.
Cancer
; 130(10): 1747-1757, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38236702
3.
The effects of exercise and diet on oxidative stress and telomere length in breast cancer survivors.
Breast Cancer Res Treat
; 199(1): 109-117, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36933050
4.
Residual cancer burden after neoadjuvant chemotherapy and long-term survival outcomes in breast cancer: a multicentre pooled analysis of 5161 patients.
Lancet Oncol
; 23(1): 149-160, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34902335
5.
A randomized study of genetic education versus usual care in tumor profiling for advanced cancer in the ECOG-ACRIN Cancer Research Group (EAQ152).
Cancer
; 128(7): 1381-1391, 2022 04 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890045
6.
A randomized trial of exercise and diet on health-related quality of life in survivors of breast cancer with overweight or obesity.
Cancer
; 127(20): 3856-3864, 2021 10 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34161602
7.
A randomized trial of exercise and diet on body composition in survivors of breast cancer with overweight or obesity.
Breast Cancer Res Treat
; 189(1): 145-154, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34089422
8.
Drug metabolising enzyme polymorphisms and chemotherapy-related ovarian failure in young breast cancer survivors.
J Obstet Gynaecol
; 41(3): 447-452, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32496149
9.
Efficacy and safety of palbociclib plus endocrine therapy in North American women with hormone receptor-positive/human epidermal growth factor receptor 2-negative metastatic breast cancer.
Breast J
; 26(3): 368-375, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-31448513
10.
Strategic recruitment of an ethnically diverse cohort of overweight survivors of breast cancer with lymphedema.
Cancer
; 124(1): 95-104, 2018 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28881471
11.
The use of a patient-reported outcome questionnaire to assess cancer survivorship concerns and psychosocial outcomes among recent survivors.
Support Care Cancer
; 25(8): 2405-2412, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28233121
12.
Palbociclib in Combination With Fulvestrant in Women With Hormone Receptor-Positive/HER2-Negative Advanced Metastatic Breast Cancer: Detailed Safety Analysis From a Multicenter, Randomized, Placebo-Controlled, Phase III Study (PALOMA-3).
Oncologist
; 21(10): 1165-1175, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27368881
13.
Cell-free DNA concentration as a biomarker of response and recurrence in HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Clin Cancer Res
; 2024 Mar 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38470545
14.
Neoadjuvant Trebananib plus Paclitaxel-based Chemotherapy for Stage II/III Breast Cancer in the Adaptively Randomized I-SPY2 Trial-Efficacy and Biomarker Discovery.
Clin Cancer Res
; 30(4): 729-740, 2024 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-38109213
15.
Protecting clinical trial participants and study integrity in the age of social media.
Cancer
; 124(24): 4610-4617, 2018 12 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-30329153
16.
Phase II Study of Palbociclib (PD-0332991) in CCND1, 2, or 3 Amplification: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocol Z1B.
Clin Cancer Res
; 29(8): 1477-1483, 2023 04 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-36853016
17.
Clinical significance and biology of circulating tumor DNA in high-risk early-stage HER2-negative breast cancer receiving neoadjuvant chemotherapy.
Cancer Cell
; 41(6): 1091-1102.e4, 2023 06 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37146605
18.
Protein signaling and drug target activation signatures to guide therapy prioritization: Therapeutic resistance and sensitivity in the I-SPY 2 Trial.
Cell Rep Med
; 4(12): 101312, 2023 12 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38086377
19.
Race, Gene Expression Signatures, and Clinical Outcomes of Patients With High-Risk Early Breast Cancer.
JAMA Netw Open
; 6(12): e2349646, 2023 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38153734
20.
The effects of exercise and diet on sex steroids in breast cancer survivors.
Endocr Relat Cancer
; 29(8): 485-493, 2022 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35639865